University of Michigan Rogel Cancer Center: all 322 studies

Page 3 of 4. Open to participants first (47), then studies with results posted, then the rest; newest registration first within each.

• Sleep Coach: A Mobile App to Address Insomnia Symptoms Among Cancer SurvivorsCompletedNCT04827459Not applicable
• Evaluating a Tailored Cognitive Behavioral Therapy for Adolescent and Young Adult Cancer PatientsTerminatedNCT04773197Not applicable
• Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)Active, not recruitingNCT04748042Phase 2
• Testing the Effect of Mindfulness for Prostatectomy OutcomesTerminatedNCT04727710Not applicable
• Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian CancerCompletedNCT04703920Phase 1
• Patient-centered Development of the Cancer Support Community's Open to Options ®Chatbot ProgramTerminatedNCT04616651Not applicable
• Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer MedicationsTerminatedNCT04595851Not applicable
• Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed GlioblastomaActive, not recruitingNCT04574856Phase 2
• Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint InhibitorsCompletedNCT04552418Early Phase 1
• Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.Active, not recruitingNCT04518748Not applicable
• Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine TumorsCompletedNCT04510311Early Phase 1
• A Pilot Study of Roadmap 2.0 in Oncology Caregivers and PatientsCompletedNCT04480541Not applicable
• Feasibility and Evaluation of a Self-care App to Enhance Purposeful LivingCompletedNCT04458168Not applicable
• Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent LymphomaTerminatedNCT04431635Phase 1
• Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate CancerActive, not recruitingNCT04396808Not applicable
• Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate CancerWithdrawnNCT04272645Phase 2
• A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate CancerActive, not recruitingNCT04194554Phase 1/2
• The SMART CART Study: Health Information TechnologyCompletedNCT04051216Not applicable
• Gemcitabine in Newly-Diagnosed Diffuse Midline GliomaWithdrawnNCT04051047Early Phase 1
• Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow TransplantationActive, not recruitingNCT03842696Phase 1/2
• APG-115 in Salivary Gland Cancer TrialActive, not recruitingNCT03781986Phase 1/2
• A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With GliomasWithdrawnNCT03632317Phase 2
• Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell LymphomaWithdrawnNCT03617484Phase 2
• Pacritinib in Relapsed/Refractory Lymphoproliferative DisordersTerminatedNCT03601819Phase 1
• The Validation of a Novel Adherence Method for Oral OncolyticsCompletedNCT03561272Not applicable
• Exercise to Reduce Chemotherapy-Induced Peripheral NeuropathyCompletedNCT03515356Not applicable
• Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed GlioblastomaTerminatedNCT03287063
• Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell LymphomaWithdrawnNCT03235869Early Phase 1
• Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based ChemotherapyTerminatedNCT03208712Early Phase 1
• Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular CarcinomaWithdrawnNCT03168152Not applicable
• Patient and Caregiver Participation Through an Educational Health Information Technology System ("BMT Roadmap") in the Context of Hematopoietic Cell TransplantationCompletedNCT03161665Not applicable
• Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to TrastuzumabCompletedNCT03135171Phase 1
• Functional Imaging in Lung SBRTCompletedNCT03121300
• Early Imaging Biomarkers in NSCLCCompletedNCT03121287
• Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)WithdrawnNCT02997956Phase 1/2
• A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CMLWithdrawnNCT02973711Phase 1/2
• Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate CancerCompletedNCT02946008Phase 1
• Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT PatientsCompletedNCT02763033Phase 2
• Clinical Outcomes, Nutritional Status, Exercise and Psychosocial Factors in Pediatric Hematopoietic Cell TransplantCompletedNCT02734797
• Prospective Study Evaluating the Use of PROSPECT to Reduce Insomnia in Patients With Early Stage Breast CancerTerminatedNCT02712437Not applicable
• Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant ChemotherapyCompletedNCT02679586Early Phase 1
• Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)WithdrawnNCT02677948Phase 1/2
• A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell CarcinomaWithdrawnNCT02649530Phase 2
• Dose Escalation Study to Determine the Maximum Tolerated Dose of the Combination of Ruxolitinib and Bortezomib in Patients With Relapsed or Refractory LymphomaCompletedNCT02613598Phase 1
• Pilot Study of Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast RadiotherapyCompletedNCT02494453
• Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing ChemoradiotherapyTerminatedNCT02485470Phase 2
• A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLCCompletedNCT02463994Early Phase 1
• A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and CaregiversCompletedNCT02409121Not applicable
• The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)Active, not recruitingNCT02400190Not applicable
• Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer PatientsCompletedNCT02338115
• Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver MutationsWithdrawnNCT02277457Early Phase 1
• A Randomized Comparative Study of a Weekly Versus Every Other Week Nurse Practitioner-led Symptom Management Clinic for Head and Neck Cancer Patients Undergoing Concurrent Chemotherapy and RadiationWithdrawnNCT02085525Not applicable
• Early Assessment of Treatment Response Using Functional Diffusion MappingCompletedNCT02064283Not applicable
• Optimization of MRI for Radiation TherapyCompletedNCT02045381
• A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck CancerWithdrawnNCT02013453Phase 2
• MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-BarrierCompletedNCT01988675
• A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic CancerCompletedNCT01986738
• Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast CancerTerminatedNCT01975597
• Combined Cytotoxic and Immune-Stimulatory Therapy for GliomaCompletedNCT01811992Phase 1
• Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive TherapyCompletedNCT01794481Not applicable
• Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial CancerWithdrawnNCT01700010Phase 2
• Effect of Radiation on Tissue for Delayed Breast ReconstructionCompletedNCT01666899Not applicable
• Cross-Sectional Study of Oral Health in Patients After Parotid-Sparing Radiation Therapy for Head and Neck CancerCompletedNCT01663246Not applicable
• Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in LymphomaWithdrawnNCT01528865Phase 1/2
• A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT)CompletedNCT01519232
• Assessment Of Liver Function in Patients Undergoing Hepatic IrradiationCompletedNCT01519219
• Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast CancerCompletedNCT01477489Phase 1
• A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung CancerTerminatedNCT01409681
• A Study of Radiation Toxicity in the Liver Using MRI-Based PerfusionCompletedNCT01210027
• A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor ResponseCompletedNCT01209962
• RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.WithdrawnNCT01188889Phase 1/2
• Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-AlphaTerminatedNCT01073436
• Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast CancerCompletedNCT00967824Phase 1/2
• Computer-Based Tailored or Standard Information for Colorectal Cancer ScreeningCompletedNCT00955188
• UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerCompletedNCT00900094
• Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance StudyCompletedNCT00858585
• Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory NeuroblastomaCompletedNCT00644696Phase 1
• A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.TerminatedNCT00637390Phase 1
• Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung CancerCompletedNCT00603057
• Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.TerminatedNCT00565227Phase 1
• A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell TransplantationCompletedNCT00405327Phase 2
• A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast CancerCompletedNCT00399321
• Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic CancerCompletedNCT00242190Phase 1/2
• Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma EsophagusTerminatedNCT00239200Phase 2
• Pre-operative Chemotherapy and Radiation Therapy for Esophageal CarcinomaCompletedNCT00230451Phase 2
• Combination Chemotherapy Treatments in Patients With Metastatic Colorectal CancerCompletedNCT00230399Phase 2
• Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic CancerCompletedNCT00176813Phase 2
• Radiation Therapy With Capecitabine in Rectal CancerTerminatedNCT00176787Phase 2
• Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal CarcinomaCompletedNCT00176774Phase 2
• Tumor-Pulsed Dendritic Cells Used as a Tumor VaccineTerminatedNCT00176761Phase 2
• Treatment for Patients With Metastatic Thyroid CancerCompletedNCT00176748Phase 2
• Capecitabine and Radiation Therapy in Advanced Pancreatic CancerTerminatedNCT00176735Not applicable
• Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression ProfilingTerminatedNCT00161278Phase 2
• Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast CancerCompletedNCT00161265
• Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and CapecitabineCompletedNCT00156312Not applicable
• Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLCCompletedNCT00156286Phase 2
• Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast CancerCompletedNCT00156273
• Feasibility Study of Evaluating Breast Cancer Patients With Ductal LavageTerminatedNCT00156260
• Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate CancerCompletedNCT00151086Phase 1/2
• Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the ProstateCompletedNCT00151073Phase 2

← University of Michigan Rogel Cancer Center overview and focus areas